Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

A novel association between relaxin receptor polymorphism and hematopoietic stem cell yield after mobilization.

Shin S, Kim J, Kim-Wanner SZ, Bönig H, Cho SR, Kim S, Choi JR, Lee KA.

PLoS One. 2017 Jun 30;12(6):e0179986. doi: 10.1371/journal.pone.0179986. eCollection 2017.

2.

Periodontal Tissue Regeneration Using Syngeneic Adipose-Derived Stromal Cells in a Mouse Model.

Lemaitre M, Monsarrat P, Blasco-Baque V, Loubières P, Burcelin R, Casteilla L, Planat-Bénard V, Kémoun P.

Stem Cells Transl Med. 2017 Feb;6(2):656-665. doi: 10.5966/sctm.2016-0028. Epub 2016 Sep 16.

3.

Poor stem cell harvest may not always be related to poor mobilization: lessons gained from a mobilization study in patients with β-thalassemia major.

Constantinou VC, Bouinta A, Karponi G, Zervou F, Papayanni PG, Stamatoyannopoulos G, Anagnostopoulos A, Yannaki E.

Transfusion. 2017 Apr;57(4):1031-1039. doi: 10.1111/trf.13951. Epub 2016 Dec 17.

PMID:
27987208
4.

Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.

Panch SR, Yau YY, Fitzhugh CD, Hsieh MM, Tisdale JF, Leitman SF.

Transfusion. 2016 May;56(5):1058-65. doi: 10.1111/trf.13551.

5.

Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani BN, Schears RM, Shaw BE, Confer DL.

Biol Blood Marrow Transplant. 2015 Jan;21(1):165-71. doi: 10.1016/j.bbmt.2014.10.007. Epub 2014 Oct 12.

6.

Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.

Panch SR, Yau YY, Kang EM, De Ravin SS, Malech HL, Leitman SF.

Transfusion. 2015 Feb;55(2):265-74. doi: 10.1111/trf.12830. Epub 2014 Aug 21.

7.

Analysis of CD34+ cell collection using two mobilization regimens for newly diagnosed multiple myeloma patients reveals the separate impact of mobilization and collection variables.

Abuabdou A, Rosenbaum ER, Usmani SZ, Barlogie B, Cottler-Fox M.

J Clin Apher. 2014 Oct;29(5):251-5. doi: 10.1002/jca.21313. Epub 2013 Dec 18.

8.

Efficacy and side effects of granulocyte collection in healthy donors.

Brockmann F, Kramer M, Bornhäuser M, Ehninger G, Hölig K.

Transfus Med Hemother. 2013 Aug;40(4):258-64. doi: 10.1159/000354093. Epub 2013 Jul 19.

9.

G-CSF in Healthy Allogeneic Stem Cell Donors.

Hölig K.

Transfus Med Hemother. 2013 Aug;40(4):225-35. doi: 10.1159/000354196. Epub 2013 Jul 22. Review.

10.

Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia.

Papanikolaou X, Rosenbaum ER, Tyler LN, Sawyer J, Heuck CJ, Barlogie B, Cottler-Fox M.

Leukemia. 2014 Apr;28(4):888-93. doi: 10.1038/leu.2013.214. Epub 2013 Jul 15.

11.

Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors.

Cohen KS, Cheng S, Larson MG, Cupples LA, McCabe EL, Wang YA, Ngwa JS, Martin RP, Klein RJ, Hashmi B, Ge Y, O'Donnell CJ, Vasan RS, Shaw SY, Wang TJ.

Blood. 2013 Feb 21;121(8):e50-6. doi: 10.1182/blood-2012-05-424846. Epub 2013 Jan 3.

12.

Significant mobilization of both conventional and regulatory T cells with AMD3100.

Kean LS, Sen S, Onabajo O, Singh K, Robertson J, Stempora L, Bonifacino AC, Metzger ME, Promislow DE, Mattapallil JJ, Donahue RE.

Blood. 2011 Dec 15;118(25):6580-90. doi: 10.1182/blood-2011-06-359331. Epub 2011 Oct 11.

13.

Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT).

Reiner AP, Lettre G, Nalls MA, Ganesh SK, Mathias R, Austin MA, Dean E, Arepalli S, Britton A, Chen Z, Couper D, Curb JD, Eaton CB, Fornage M, Grant SF, Harris TB, Hernandez D, Kamatini N, Keating BJ, Kubo M, LaCroix A, Lange LA, Liu S, Lohman K, Meng Y, Mohler ER 3rd, Musani S, Nakamura Y, O'Donnell CJ, Okada Y, Palmer CD, Papanicolaou GJ, Patel KV, Singleton AB, Takahashi A, Tang H, Taylor HA Jr, Taylor K, Thomson C, Yanek LR, Yang L, Ziv E, Zonderman AB, Folsom AR, Evans MK, Liu Y, Becker DM, Snively BM, Wilson JG.

PLoS Genet. 2011 Jun;7(6):e1002108. doi: 10.1371/journal.pgen.1002108. Epub 2011 Jun 30.

14.

A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteers.

Lemery SJ, Hsieh MM, Smith A, Rao S, Khuu HM, Theresa D, Viano JM, Cook L, Goodwin R, Boss C, Calandra G, Geller N, Tisdale J, Childs R.

Br J Haematol. 2011 Apr;153(1):66-75. doi: 10.1111/j.1365-2141.2010.08547.x. Epub 2011 Feb 24.

15.

Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?

Hsieh MM, Tisdale JF, Rodgers GP, Young NS, Trimble EL, Little RF.

J Clin Oncol. 2010 Apr 1;28(10):1633-7. doi: 10.1200/JCO.2009.24.3881. Epub 2010 Mar 1. No abstract available.

16.
17.

Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

Donahue RE, Jin P, Bonifacino AC, Metzger ME, Ren J, Wang E, Stroncek DF.

Blood. 2009 Sep 17;114(12):2530-41. doi: 10.1182/blood-2009-04-214403. Epub 2009 Jul 14.

18.

Non-myeloablative allogeneic hematopoietic stem cell transplantation.

Shelburne N, Bevans M.

Semin Oncol Nurs. 2009 May;25(2):120-8. doi: 10.1016/j.soncn.2009.03.006. Review.

19.

Supplemental Content

Support Center